Healthy postmenopausal women receiving hrt are not at risk for early coronary events: Results from 2 large clinical trials

被引：0
|
作者：
Constantine, GD [1 ]
Pickar, JH [1 ]
Trott, EA [1 ]
机构：
[1] Wyeth Ayerst Res, St Petersburg 191011, Russia
来源：
WOMEN'S HEALTH AND MENOPAUSE: NEW STRATEGIES - IMPROVED QUALITY OF LIFE | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：231 / 238
页数：8
相关论文
共 50 条
  • [1] Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women - Results from 2 large clinical trials
    Lobo, RA
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (05) : 482 - 484
  • [2] Identification of early postmenopausal women with no bone response to HRT:: Results of a five-year clinical trial
    Komulainen, M
    Kröger, H
    Tuppurainen, MT
    Heikkinen, AM
    Honkanen, R
    Saarikoski, S
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 (03) : 211 - 218
  • [3] Identification of Early Postmenopausal Women with No Bone Response to HRT: Results of a Five-Year Clinical Trial
    M. Komulainen
    H. Kröger
    M. T. Tuppurainen
    A.-M. Heikkinen
    R. Honkanen
    S. Saarikoski
    Osteoporosis International, 2000, 11 : 211 - 218
  • [4] Glycemic control predicts survival from clinical events in high-risk postmenopausal women with coronary artery disease
    Vaidya, D
    Kelemen, MD
    Bittner, V
    Hsia, J
    Cobb, FR
    Ouyang, P
    CIRCULATION, 2005, 111 (04) : E80 - E80
  • [5] Postmenopausal hormone replacement therapy, lipoprotein(a) and coronary heart disease events in a cohort of 2,853 healthy women
    Nguyen, TT
    Hodge, DO
    Lohse, CM
    Heshmati, HM
    CIRCULATION, 2000, 102 (18) : 837 - 837
  • [6] Postmenopausal Hormone Use and the Risk of Nephrolithiasis Results From the Women's Health Initiative Hormone Therapy Trials
    Maalouf, Naim M.
    Sato, Alicia H.
    Welch, Brian J.
    Howard, Barbara V.
    Cochrane, Barbara B.
    Sakhaee, Khashayar
    Robbins, John A.
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (18) : 1678 - 1685
  • [7] Age at Menarche and Menopause, Reproductive Lifespan, and Risk of Cardiovascular Events Among Chinese Postmenopausal Women: Results From a Large National Representative Cohort Study
    Chen, Lu
    Hu, Zhen
    Wang, Xin
    Song, Yuxin
    Chen, Zuo
    Zhang, Linfeng
    Zheng, Congyi
    Vallis, Jillian
    Zhou, Haoqi
    Cao, Xue
    Tian, Yixin
    Cai, Jiayin
    Gu, Runqing
    Huang, Yilin
    Wang, Zengwu
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Relationships between age and prior use of HRT on vertebral fracture risk reduction with raloxifene in postmenopausal women: Results from the MORE trial.
    Johnell, O
    Kanis, JA
    Sarkar, S
    Wu, W
    de Laet, C
    Oden, A
    Pavo, I
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S414 - S414
  • [9] Lasofoxifene and Cardiovascular Events in Postmenopausal Women With Osteoporosis Five-Year Results From the Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) Trial
    Ensrud, Kristine
    LaCroix, Andrea
    Thompson, John R.
    Thompson, David D.
    Eastell, Richard
    Reid, David M.
    Vukicevic, Slobodan
    Cauley, Jane
    Barrett-Connor, Elizabeth
    Armstrong, Roisin
    Welty, Francine
    Cummings, Steven
    CIRCULATION, 2010, 122 (17) : 1716 - +
  • [10] Age of menopause and fracture risk in postmenopausal women randomized to calcium plus vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials
    Sullivan, Shannon D.
    Lehman, Amy
    Nathan, Nisha K.
    Thomson, Cynthia A.
    Howard, Barbara V.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (04): : 371 - 378
12345